Greenstone: Your Generics Partner for More Than 20 Years

Publication
Article
Generic SupplementsGeneric Supplement 2015
0

Greenstone offers a robust, diverse, and growing portfolio of generic products of some of the most-prescribed branded pharmaceutical products on the market.

Greenstone LLC offers a robust, diverse, and growing portfolio of generic products of some of the most-prescribed branded pharmaceutical products on the market.

Greenstone’s portfolio includes authorized generics that are generally made and sold under the NDA of the brand-name drug. This means they have the same efficacy and safety profiles, and contain the same active and inactive ingredients. The Food and Drug Administration recommends that generic drugs should closely mimic the physical attributes, including the size and shape, of their brand-name equivalent.1 Greenstone authorized generics are typically the same size, shape, and color of their brand-name equivalents.

A goal of Greenstone’s is to maintain a dependable supply of generic medicines. As a subsidiary of Pfizer, one of the world’s premier biopharmaceutical companies, Greenstone is held to the same high industry standards, demonstrating a commitment to excellence in manufacturing and supply, from the procurement of raw materials to product delivery. As your partner, Greenstone is dedicated to putting reliable generic medications in the hands of patients, while consistently delivering value to its customers.

For more than 20 years, Greenstone has been committed to quality, value, and excellence in everything it does—from the standards of its generics to its dedication to reliable customer service—with the goal of helping patients live healthier lives.

Learn about how you can partner with Greenstone, by visiting GreenstoneLLC. com, or calling Greenstone Customer Service at 1-800-447-3360.

References

  • US Food and Drug Administration. Size, Shape, and Other Physical Attributes of Generic Tablets and Capsules. June 2015.

Related Videos
Practice Pearl #1 Active Surveillance vs Treatment in Patients with NETs
© 2024 MJH Life Sciences

All rights reserved.